Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB
[thumbnail of Supplementary Material] MS Word (Supplementary Material)
687kB

Item Type:Article
Title:Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD
Creators Name:Chan, F., Berhanu, D., Samadzadeh, S., Francis, A., Asgari, N., Paul, F., Leite, M.I., Geraldes, R. and Palace, J.
Abstract:BACKGROUND: Smoking and vascular risk factors (VRFs) are reported to have adverse effects in multiple sclerosis but data are limited in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). This study aimed to measure their impact on disability. METHODS: Smoking status was defined as never, past or current smokers and VRF comprised of ⩾1: hypertension, dyslipidemia, high body mass index or diabetes. Logistic regression models were fitted to predict their influence on recovery from attack and attack. RESULTS: A total of 442 patients were included. Current MOGAD smokers had a higher risk of disability from onset attack and first ON attack than never smokers (odds ratio (OR) 2.9, 95% confidence interval (CI) 1.3-6.9; OR 3.3, 95% CI 1.4-7.8). VRF in MOGAD was not predictive of disability. Current AQP4-NMOSD smokers and VRFs had a higher risk of residual disability from onset attacks (OR 7.5, 95% CI 2.1-27.7; OR 1.9, 95% CI 1.0-3.4). VRF was associated with higher risk of visual disability (OR 2.6, 95% CI 1.08-6.46) while smoking status was not. CONCLUSIONS: Current smoking status detrimentally influenced onset attack recovery in AQP4-NMOSD and MOGAD patients, including visual recovery in MOGAD. Non-smoking VRFs influenced clinical and visual outcomes in AQP4-NMOSD.
Keywords:Smoking, Comorbidities, Vascular Risk Factors, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody Disease, Disability
Source:Multiple Sclerosis Journal
ISSN:1352-4585
Publisher:Sage Publications
Page Range:13524585251325069
Date:15 March 2025
Official Publication:https://doi.org/10.1177/13524585251325069
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library